“…The antiviral effects of DFMO on various viruses have also been demonstrated ( Masalova et al, 2017 ; Mounce et al, 2016a ; Mounce et al, 2016b ; Tuomi et al, 1980 ), suggesting that DFMO is a potential broad-spectrum antiviral drug. Other polyamine-targeted agents, including DENSpm (an inducer of SAT1), MDL 72757 (an inhibitor of PAOX) and other drugs regulating the hypusination of eIF5A, such as N1-guanyl-1,7-diamine-heptane, ciclopirox, and deferiprone, are promising antivirals as well ( Fedorova et al, 2019 ; Mounce et al, 2016a ; Olsen and Connor, 2017 ; Olsen et al, 2018 ; Olsen et al, 2016 ). Here, we have shown DFMO or DENSpm administration caused polyamine depletion, and also exhibited antiviral activities against PRRSV, implying their potential as candidate polyamine-targeted agents for the future development of safe and efficient antivirals for PRRSV, and even SARS-CoV, MERS-CoV, SARS-CoV-2, individually, or in combination with other antiviral drugs.…”